Home » Topics » Conferences

Conferences
RSS

Aliskiren/amlodipine combination effective in hypertension

July 9, 2010

Intratumoral TG-4023 gene therapy is feasible in patients with liver cancer

July 9, 2010

Phase I and II data reported on blinatumomab in hematological cancers

July 9, 2010

MicroRNA expression profiles associated with malignancy potential of pancreatic cystic tumors

July 9, 2010

First-in-human data presented on oncolytic agent MNRP-1685A

July 8, 2010

CNTO-888 well tolerated in patients with advanced solid tumors

July 8, 2010

Enzastaurin shows potential in phase II follicular lymphoma trial

July 8, 2010

Phase I data reported on PCI-32765 in non-Hodgkin's lymphoma

July 8, 2010

Best response of stable disease seen in phase I BI-811283 trial in solid tumors

July 8, 2010

Scientists present tissue-specific anti-inflammatory NF-kappaB inhibitor LSC-1

July 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...